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Abstract
Background: Vascular malformations with arteriovenous shunt components can cause significant disability, chronic
pain, and functional impairment. Effective treatment may require serial procedures, yet an imaging modality
optimized to control cost and reduce radiation exposure in this predominantly pediatric population has not yet
been identified.
Methods and Results: We describe the use of contrast-enhanced sonography as a novel tool to define vascular
anatomy and localize arteriovenous shunting in a young patient with a symptomatic vascular malformation.
Conclusions: This method may effectively reduce radiation exposure and cost, and additionally provide unique
information about arteriovenous shunting, offering a novel imaging application for patients with these conditions.
Background
Vascular malformations (VM) are congenital lesions
with diverse clinical manifestations. In contrast to
hemangiomas, a separate category of vascular tumors
which tend to involute spontaneously, VM often grow
in proportion with the child but may expand at an
accelerated pace [1]. VM can occur throughout the
body, involve multiple vessel types, and may be localized
or extensive [2]. Although criteria have been developed
for classifying vascular malformations according to flow
velocity and vessel type [3], diagnosis of these heteroge-
neous lesions remains challenging.
While these abnormalities may be asymptomatic, VM
become clinically important when associated with disfig-
urement, functional impairment, pain, infection, and ser-
ious bleeding [4,5]. These patients require treatment,
which varies according to the specific lesion, its location,
functional impairment, and goals of therapy. Assembly
of a multi-disciplinary team is advantageous when plan-
ning therapy. Further, precise characterization of proble-
matic lesions is critically important both in designing
the approach and understanding, likely outcomes (such
as the potential need for multiple treatments). For
example, malformations with arteriovenous shunting
may require embolization [1,6], whereas sclerotherapy is
the treatment of choice for venous and macrocystic lym-
phatic malformations [7,8]. Among venous malforma-
tions treated with sclerotherapy, smaller well-defined
lesions have been associated with better outcomes than
larger ill-defined lesions [6].
Although VM can be partly characterized on the basis of
history and physical examination, imaging is commonly
required for better identification of abnormal structures in
patients with atypical presentations, and to assess the
extent of a lesion before and after treatment[9]. Magnetic
resonance (MR) imaging is widely considered to be a lead-
ing modality for visualizing malformations in relationship
to adjacent structures [10,11]. However, the information
provided by MR imaging is more sensitive than it is speci-
fic [10,12]. Moreover, MR is difficult to use when guiding
interventions in real time, and is time- and cost-intensive,
frequently requiring sedation or anesthesia for adequate
imaging in children. Conversely, ultrasound (US) imaging
with and without color Doppler is frequently used in initial
screenings because of its availability, safety, relatively low
cost, and ability to display flow velocity and to differentiate
between types of vascular lesions in real time. However,
color Doppler imaging is limited in its ability to detect
very small vessels with low or erratic flow [9].
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nostic accuracy for echocardiography, and has been
used to enhance parenchymal tumor evaluation in clini-
cal and research settings [13,14]. Contrast-enhanced
ultrasound (CEUS) enables visualization of vascular
architecture in real time, without exposing the patient
to ionizing radiation; this may be particularly advanta-
geous to populations in whom such exposure is of con-
cern (such as children) or in whom serial examinations
may be necessary (such as patients with vascular malfor-
mations). These features suggest that CEUS may be use-
ful to supplement or even replace MRI or conventional
angiography in some instances. We report the first case
in which CEUS has been used to evaluate a vascular
malformation.
Methods
A 26-year-old woman with a mass in her right calf since
the age of 7 presented with continuous pain and
swelling in the area. Initial MR imaging demonstrated a
vascular malformation (Figure 1). Arteriovenous shunt-
ing signifying some component of an arteriovenous mal-
formation was suspected based on the presenting
complaints and clinical characteristics of the tense, swol-
len lesion. Diagnostic arteriography showed a soft tissue
malformation with three regions of arteriovenous shunt-
ing identified, supplied predominantly by sural branches
of the right popliteal artery. Sonography with contrast-
enhanced and conventional two-dimensional (2D) color
and pulsed Doppler was performed to obtain additional
arteriovenous shunt information prior to therapeutic
embolization.
Sonographic imaging was performed initially using a
Phillips iE33 ultrasound machine with a 2D transducer
(S5-1,1. 1.7 - 3.4 MHz). The microbubble contrast agent
(Definity™: Lantheus Medical, Billerica, MA) was pre-
activated for 45 seconds using a standard diffusion
device (Vialmix, Boston Myers Squibb Medical Image.
Figure 1 MR and angiographic studies suggestive of multiple arteriovenous shunts supplying a venous malformation. A 26-year-old
female with a painful vascular malformation of the right lower leg with a clinically obvious venous component was evaluated for arteriovenous
shunting. (A) Parasagittal T2-weighted MR image with intravenous gadolinium contrast demonstrated an infiltrative vascular malformation in the
right gastrocnemius (arrows). (B) Digital subtraction angiogram of the right leg in a lateral projection during the arterial phase revealed
arteriovenous shunting (arrow) within the vascular malformation, supplied by sural branches of the right popliteal artery.
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ine prior to administration. Areas of arteriovenous
shunting overlying her right gastrocnemius muscle, initi-
ally visualized at catheter angiography, were scanned
with a 2D transducer from the level of the popliteal
fossa through the level of the Achilles tendon. Pulsed
Doppler interrogation was performed at each specific
arteriovenous shunt. After visualizing the whole mass,
the transducer was re-positioned at each shunting area
using color Doppler imaging. Next, one ml of diluted
contrast agent was slowly infused intravenously (1 ml/
min). A second one ml dose was administered after 20
minutes. Images were acquired at a low mechanical
index (MI 0.31) using the 2D transducer. The contralat-
eral (left) lower leg was scanned as a control study, also
using the 2D transducer.
Results
Two-dimensional and color Doppler sonography
revealed a multilocular low-flow vascular structure
compatible with a venous malformation. Echogenicity
and flow signals were greatly enhanced following con-
trast administration (video clips, Additional Files 1 and
2). However, no such abnormalities were present in
the unaffected, contralateral leg. Pulsed Doppler stu-
dies localized three specific foci of arteriovenous
shunting 3-5 cm below the popliteal fossa (PF) charac-
terized by low-resistance flow, detected as a normal
venous waveform with superimposed arterial pulsatile
flow (Figure 2).
As a result of the information obtained from this and
her prior diagnostic imaging, the patient was treated via
a transarterial approach, rather than rather than employ-
ing a direct percutaneous approach indicated for less
complicated venous malformations [6]. One feeding
artery was embolized with acrylic glue (Trufil™ NBCA:
Codman Cordis, Rayhnam, MA) and three others were
sclerosed with absolute ethanol. Shunts were not
detected by post-procedure contrast-enhanced ultra-
sound, although this study was technically limited and
Figure 2 Contrast-enhanced and color Doppler ultrasound studies. Two-dimensional ultrasound images were obtained at the level of 3-5
cm below the popliteal fossa (PF). The color Doppler studies demonstrated no abnormal vasculature in the same location on the unaffected leg
(A), but multiple tortuous vessel structures with pulsatile flow compatible with venous malformation fed by arteriovenous shunts (B). Pulse
Doppler studies identified three specific foci of arteriovenous shunts characterized by low-resistance flow, composed of a normal venous
waveform with superimposed arterial pulsatile flow (C). The same studies in the unaffected leg demonstrated a normal arterial wave form (D).
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ment images.
Discussion
Vascular malformations can be a source of significant
disability. Appropriate intervention requires accurate
characterization of malformation anatomy and vascular
architecture. In particular, while identification of arterio-
venous shunts is critical to control painful symptoms,
techniques to identify shunts can involve repeated expo-
sure to ionizing radiation, contrast, and/or time-inten-
sive and expensive modalities. While sonography with
color Doppler is inexpensive, widely available, and safe,
it has not been as useful for smaller vessels with low-
level perfusion [9]. Of 51 venous malformations evalu-
ated by Trop et al [12], flow in eight malformations
could not be detected. The development of sonographic
contrast (microbubbles) has the potential to enhance
low-flow sonographic echogenicity and Doppler signal,
extending the utility of this modality in patients with
vascular malformations. In particular, CEUS may offer
improved detection of small arteriovenous shunts, as
present in this patient with pain and edema in the
affected leg. Arteriovenous shunting is important to
identify and localize prior to treatment, since it may
alter the type of intervention required (e.g. may necessi-
tate embolization instead of or as an adjunct to
sclerotherapy).
In this case, arteriovenous shunting was suspected due
to the pain and progressive swelling associated with the
lesion. Multiple arteriovenous shunts were indeed visua-
lized using contrast-enhanced ultrasound, including at
least one region that had not been clearly apparent on
either MRI or conventional diagnostic angiography, and
were confirmed at the time of therapeutic angiography.
As a result of the additional information obtained from
this diagnostic imaging, the patient was treated transar-
terially, with combined embolization of a feeding artery
and sclerosis of three communicating venous channels.
Malformations with substantial venous components
often require staged treatments [2,7]. Multiple treat-
ments are often necessary for several reasons. First,
venous malformations may recanalize [7,10]. This limita-
tion cannot be overcome by increased dosing of sclero-
sant, since these agents (such as ethanol) act by
damaging cells and, at higher doses, can cause skin
necrosis, hemolysis, and peripheral nerve injury [11,15].
Furthermore, in venous malformations involving arterio-
venous shunt components, new or previously inapparent
shunts may cause recurrence of pain or swelling.
Because the majority of patients presenting with vascu-
lar malformations are children, an optimal imaging
strategy would maximize detection of arteriovenous
shunts, while minimizing radiation exposure, iodinated
contrast load needed for conventional angiography,
requirement for sedation or anesthesia, and cost.
An additional advantage of an optimal imaging strat-
egy might include the real-time ability to guide interven-
tion. Lewin et al [6] added trace amounts of MR
contrast to ethanolamine and were able to safely per-
form MR imaging-guided sclerotherapy. Similarly,
microbubble contrast could be added to a sclerosing
agent in order to guide treatment by sonography, which
would reduce the radiation load to patients and health-
care workers. Intriguingly, microbubbles have proven to
be highly customizable. For example, microbubbles can
be engineered to bind specific epitopes in vasculature,
widely demonstrated in animal models and in develop-
ment for humans [16]. This capability could be very
useful in treatment of patients whose vascular anomalies
affect specific subsets of vessels, or which stem from
particular mutations.
Conclusions
We report the use of CEUS in a young patient with a
complex, disabling vascular malformation. Our experi-
ence suggests that this modality has the potential to
supplement or replace current vascular imaging modal-
ities. Further, CEUS may have particular utility in detec-
tion of small arteriovenous shunts that are more
difficult to detect with conventional sonography or MR
imaging. The plasticity of microbubbles as a contrast
platform may offer particular advantages for future
development of novel targeted intravascular therapies.
Additional material
Additional file 1: Video clip 1: Area of vascular anomaly with
swelling at time 0 of contrast administration. Contrast enhanced
ultrasound studies permit detection of small vessels not visualized on
conventional ultrasound. This technique allows identification of smaller
anomalous vessels, which were not detectable by non-contrast B mode
sonography, as in this pre-contrast video clip. Such vasculature may
contribute to the pathophysiology of the anomaly, and thus identifying
contributory vessels may be useful in planning interventions.
Additional file 2: Video clip 2: Area of vascular anomaly two
minutes after contrast administration. Vasculature can be detected in
the region clinically involved by malformation after contrast
administration.
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